section name header

Pronunciation ⬇

bumetanide: byoo-MET-a-nide

furosemide: fur-OH-se-mide

torsemide: TORE-se-mide

Classifications ⬆ ⬇

Therapeutic Classification: diuretics

Pharmacologic Classification: loop diuretics

Indications ⬆ ⬇

REMS


Unlabeled Use: Furosemide

Action ⬆ ⬇

  • Inhibit the reabsorption of sodium and chloride from the loop of Henle and distal renal tubule.
  • Increase renal excretion of water, sodium, chloride, magnesium, hydrogen, and calcium.
  • May have renal and peripheral vasodilatory effects.
  • Effectiveness persists in impaired renal function.
Therapeutic effects:
  • Diuresis and subsequent mobilization of excess fluid (edema, pleural effusions).
  • Decreased BP.

Pharmacokinetics ⬆ ⬇

Absorption: Bumetanide: well absorbed after oral or IM administration. Furosemide: 60–75% absorbed following oral administration; also absorbed from IM sites; IV administration results in complete availability; 99.6% absorbed after SUBQ administration. Torsemide: 80% absorbed following oral administration.

Distribution: Bumetanide and Torsemide: well distributed to tissues.

Protein Binding: All are >91%.

Metabolism/Excretion: Bumetanide: Partially metabolized by the liver; 50% eliminated unchanged by the kidneys; 20% excreted in feces. Furosemide: Some metabolism by liver (30–40%), some nonhepatic metabolism, and some renal excretion as unchanged drug. Torsemide: Primarily metabolized by CYP2C9, with minor metabolism via CYP2C8 and CYP2C18. 80% metabolized by liver; 20% excreted in urine.

Half-Life: Bumetanide: 60–90 min (6–15 hr in neonates); Furosemide: 30–120 min (↑ in renal impairment and neonates, markedly ↑ in hepatic impairment); Torsemide: 210 min.

Time/Action Profile ⬆ ⬇

( diuretic effect)

ROUTEONSETPEAKDURATION
Bumetanide–PO30–60 min1–2 hr3–6 hr
Bumetanide–IM40 min1–2 hr4–6 hr
Bumetanide–IVwithin min15–45 min3–6 hr
Furosemide–PO30–60 min1–2 hr6–8 hr
Furosemide–IM10–30 minunknown4–8 hr
Furosemide–IV5 min30 min2 hr
Furosemide–SUBQunknownunknown8 hr
Torsemide–POwithin 60 min60–120 min6–8 hr



Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

CV: hypotension

Derm: ERYTHEMA MULTIFORME (EM), photosensitivity, pruritus, rash, STEVENS-JOHNSON SYNDROME, TOXIC EPIDERMAL NECROLYSIS, urticaria

EENT: hearing loss, tinnitus

Endo: hyperglycemia

F and E: dehydration, hypochloremia, hypokalemia, hypomagnesemia, hyponatremia, hypovolemia, metabolic alkalosis

GI: ↑liver enzymes (furosemide), constipation, diarrhea, dry mouth, dyspepsia, nausea, vomiting

GU: acute renal failure, renal impairment, excessive urination

Hemat: blood dyscrasias (furosemide)

Metab: hypercholesterolemia, hypertriglyceridemia, hyperuricemia

MS: arthralgia (torsemide), muscle cramps, myalgia (torsemide)

Neuro: dizziness, encephalopathy (bumetanide and furosemide), headache, insomnia(torsemide), nervousness (torsemide)

Interactions ⬆ ⬇

Drug-drug:

Route/Dosage ⬆ ⬇

Bumetanide

Furosemide

Torsemide

Availability ⬆ ⬇

Bumetanide

(Generic available)

Furosemide

(Generic available)

Torsemide

(Generic available)

Assessment ⬆ ⬇

Lab Test Considerations:

Implementation ⬆ ⬇

IV Administration:

Bumetanide

Furosemide

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

US Brand Names ⬆ ⬇

bumetanide: Bumex,

furosemide: Furoscix, Lasix,

torsemide: Demadex, Soaanz

Canadian Brand Names ⬆

bumetanide: Burinex,

furosemide: Lasix Special